Malvern Instruments to acquire MicroCal business from GE Healthcare Life Sciences
June 4, 2014
Malvern, UK: Malvern Instruments Ltd. (Malvern, UK) announced today that it has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal™ microcalorimetry business. Financial terms were not disclosed. The acquisition, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014. MicroCal has a 30-year [...]
New Humidifier Accessory from Markes set to improve analysis of chemical emissions from materials
June 4, 2014
Llantrisant, UK -- Markes International, a world leader in instrumentation for trace organic analysis, has announced the launch of a Humidifier Accessory, which extends the capability of their Micro-Chamber/Thermal Extractor™ by supplying it with humidified air or gas. Markes’ Micro-Chamber/Thermal Extractor has gained popularity over recent years as a versatile tool for rapidly sampling volatile [...]
June 4, 2014
Hercules, CA — — Bio-Rad Laboratories, Inc. today announced the launch of its SsoAdvanced™ PreAmp Supermix and PrimePCR™ PreAmp Assays. The supermix is formulated to permit unbiased, target-specific preamplification of cDNA or genomic DNA (gDNA), which allows researchers to stretch their limited nucleic acid samples. PrimePCR PreAmp assays are wet-lab validated preamplification primers that work [...]
Hiden Biostream System for Biofuel Research
June 4, 2014
Warrington, UK -- The Hiden Biostream system is a research-grade mass spectrometer developed specifically for applications in biofuel research to provide real-time analysis of dissolved gases and vapours in aqueous solutions, identifying and quantifying in real time gaseous species with molecular weights up to 300 amu. Algae-based biofuels such as biodiesel or bioethanol can have [...]
Omixon and CHOP Collaborate on NGS-based HLA Genotyping
June 4, 2014
Cambridge, MA -- Global bioinformatics software company Omixon, headquartered in Budapest with US offices in Cambridge, MA, announces an exclusive licensing agreement with The Children’s Hospital of Philadelphia (CHOP) to commercialize a new Next Generation Sequencing (NGS) HLA genotyping assay, for use on the Illumina® MiSeq sequencing platform. The Illumina-specific HLA genotyping protocol was developed [...]
June 3, 2014
CAMBRIDGE, Mass.-- LabCentral, a first-of-its-kind shared laboratory space designed as a launchpad for high-potential life-sciences and biotech startups, is announcing important new milestones as it continues to make its mark as the place to be for science innovation. LabCentral has launched a new website and secured significant new sponsor agreements. In addition, a new partnership [...]
ASU embarks on $9 million next phase of an effort to assess rapidly an absorbed radiation dose
June 3, 2014
Arizona State University’s Biodesign Institute announced today it is entering a new, $9 million phase of a multi-million, multi-institutional development project to produce a diagnostic test to measure rapidly an individual’s level of absorption of ionizing radiation in the event of an unplanned radiological or nuclear event. The project is part of a potential $31.2 [...]
Morpho’s Itemiser DX Surpasses 5,000 Units Shipped Worldwide
June 3, 2014
WILMINGTON, Mass. - Morpho (Safran), through its subsidiary Morpho Detection, today announced it has surpassed 5,000 desktop Itemiser® DX explosives trace detectors (ETD) shipped worldwide. A lightweight, portable desktop system, Itemiser DX can detect residue from explosives and narcotics on skin,clothing, parcels, bags, cargo, vehicles and other surfaces. First introduced in 2009 and currently certified [...]
Repligen Acquires Bioprocessing Business of Refine Technology
June 3, 2014
WALTHAM, Mass. -- Repligen Corporation (RGEN) announced today that it has acquired the business of Refine Technology ("Refine"), including Refine's Alternating Tangential Flow ("ATF") System, a market-leading device used to significantly increase product yield during the fermentation step of the biologic drug manufacturing process. The acquisition strengthens Repligen's bioprocessing business by adding a profitable and [...]
bioMérieux Announces the Appointment of Stefan Willemsen as President and CEO of bioMérieux Inc.
June 3, 2014
Durham, NC -- bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce the appointment of Stefan Willemsen as President and CEO of bioMérieux Inc. He will lead all administrative, commercial and production operations of the bioMérieux Group in the recently created North and Latin America region. Mr. Willemsen will [...]
